Exo-BSA@dBET6 can elevate cellular ROS levels, reduce mitochondrial membrane potential, and enhance the expression of the apoptotic protein caspase-3 by specifically targeting the BRD4 protein, ultimately inducing tumor cell apoptosis. Here, CASP3 is linked to neoplasm.